Thalidomide is a medication used to manage and treat advanced leprosy and multiple myeloma, and various other solid and hematologic malignancies. It is in the immunomodulatory class of medications. This activity reviews the indication, action, and contraindications for thalidomide as a valuable agent in the treatment of leprosy, multiple myeloma, and other malignancies when applicable. This activity will highlight the mechanism of action, adverse event profile, and other key factors pertinent for interprofessional team members managing the care of patients with leprosy, multiple myeloma, and other malignancies and their related conditions.

**Objectives:**
- Describe the unique molecular composition of thalidomide and how this affects the drugâ€™s therapeutic and adverse effects.

- Identify the most common adverse effects associated with thalidomide therapy. 
- Summarize proper treatment and responses to thalidomide toxicity. 
- Explain the importance of the interprofessional healthcare team monitoring patients taking thalidomide, especially females of reproductive age.